Efficacy and Safety of Topiramate in the Treatment of Obese Subjects With Essential Hypertension
- 15 July 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (2) , 243-251
- https://doi.org/10.1016/j.amjcard.2005.03.053
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjectsInternational Journal of Obesity, 2004
- Influence of Weight Reduction on Blood PressureHypertension, 2003
- A 6-Month Randomized, Placebo-Controlled, Dose-Ranging Trial of Topiramate for Weight Loss in ObesityObesity Research, 2003
- Obesity and the Environment: Where Do We Go from Here?Science, 2003
- The effects of topiramate and sex hormones on energy balance of male and female ratsInternational Journal of Obesity, 2002
- Overweight, Obesity, and Blood Pressure: The Effects of Modest Weight ReductionObesity Research, 2000
- Topiramate as an Inhibitor of Carbonic Anhydrase IsoenzymesEpilepsia, 2000
- Step‐down multiple tests for comparing treatments with a control in unbalanced one‐way layoutsStatistics in Medicine, 1991
- The experimental evidence for weight-loss treatment of essential hypertension: a critical review.American Journal of Public Health, 1982
- Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive PatientsNew England Journal of Medicine, 1978